To help grain the fluid from his lung là gì năm 2024

Fluid around the lung (pleural effusion) is a potentially dangerous condition that can masquerade as something less worrisome. What may seem like chest pain or coughing due to a bad cold could actually have serious health ramifications. It’s not that rare, either. More than 1.5 million people are diagnosed with pleural effusion in the United States each year.

Pleural effusion occurs when fluid builds up in the space between the lung and the chest wall. This can happen for many different reasons, including pneumonia or complications from heart, liver, or kidney disease. Another reason could be as a side effect from cancer. “One of the most common reasons pleural effusion develops is due to congestive heart failure,” says Jonathan Puchalski, MD, a pulmonologist at Yale Medicine.

What are the symptoms of pleural effusion?

The symptoms of pleural effusion can range from none to shortness of breath to coughing, among others. The greater the build-up of fluid, the more likely symptoms will be noticeable.

In addition to excess fluid, the tissue around the lung may become inflamed, which can cause chest pain. In extreme cases, a person can have up to four liters of excess fluid in the chest. It's very uncomfortable. “Imagine trying to breathe with two soda bottles pushed up against your lungs,” Dr. Puchalski says.

How is fluid around the lung diagnosed?

A physician will usually diagnosis pleural effusion based on interviewing the patient about symptoms and a physical examination. To confirm a diagnosis, he or she may also request an imaging test, which could be a chest X-ray, ultrasound, or computed tomography (CT) scan. To further help with diagnosis, a doctor may extract a sample of the excess fluid to be tested to determine the cause.

How is fluid around the lung treated?

The best way is to treat the cause of the effusion. If the cause is pneumonia, a doctor will likely prescribe antibiotics to treat the infection, which may also cause the fluid to go away. If fluid build-up has been caused by congestive heart failure, a physician will likely prescribe diuretics, such as Lasix, for treatment.

For large pleural effusions, or for those with an unknown cause, the fluid will need to be drained through a procedure called thoracentesis. This involves inserting a needle in the space between the lung and the chest wall and draining the liquid. In these cases, a doctor may also send a sample of fluid to be tested for other causes, such as lung cancer, for example. Some patients may require a pleural drain that is inserted through the skin so that the buildup of fluid can be drained repeatedly without the need for repeated thoracentesis.

What are the chances a pleural effusion will happen again?

“My patients always want to know if it will come back,” says Dr. Puchalski. “Sometimes it does and sometimes it doesn’t.” He explains that the risk of recurrence is based mostly on the cause of the pleural effusion in the first place. For lung cancer patients, he explains, the buildup is likely to occur again.

What makes Yale Medicine’s approach to pleural effusion special?

At Yale Medicine, patients receive care from a team of physicians who specialize in dealing with pleural effusions. The clinical care team includes a physician assistant and an advanced practice registered nurse who are trained in this subspecialty. What makes Yale especially unique, Dr. Puchalski adds, is our ability to perform bilateral thoracenteses. This means that a patient can have fluid build-up removed from both lung areas in a single treatment, rather than scheduling two separate procedures. Patients can do this at Yale Medicine, Dr. Puchalski explains, due to a highly-trained staff.

Another unique aspect of care at Yale Medicine is that doctors rarely ask patients to stop taking blood-thinning medication before the procedure. Many other medical centers require that patients stop blood thinners one week before the procedure, Dr. Puchalski says. However, Yale researchers conducted thorough research and found that this precaution did not affect the final outcome of the procedure. “We don’t make patients wait to undergo the procedure,” he says.

This review analyses the mechanisms by which lung fluid balance is strictly controlled in the air-blood barrier (ABB). Relatively large trans-endothelial and trans-epithelial Starling pressure gradients result in a minimal flow across the ABB thanks to low microvascular permeability aided by the macromolecular structure of the interstitial matrix. These edema safety factors are lost when the integrity of the interstitial matrix is damaged. The result is that small Starling pressure gradients, acting on a progressively expanding alveolar barrier with high permeability, generate a high transvascular flow that causes alveolar flooding in minutes. We modeled the trans-endothelial and trans-epithelial Starling pressure gradients under control conditions, as well as under increasing alveolar pressure (Palv) conditions of up to 25 cmH2O. We referred to the wet-to-dry weight (W/D) ratio, a specific index of lung water balance, to be correlated with the functional state of the interstitial structure. W/D averages ∼5 in control and might increase by up to ∼9 in severe edema, corresponding to ∼70% loss in the integrity of the native matrix. Factors buffering edemagenic conditions include: (i) an interstitial capacity for fluid accumulation located in the thick portion of ABB, (ii) the increase in interstitial pressure due to water binding by hyaluronan (the “safety factor” opposing the filtration gradient), and (iii) increased lymphatic flow. Inflammatory factors causing lung tissue damage include those of bacterial/viral and those of sterile nature. Production of reactive oxygen species (ROS) during hypoxia or hyperoxia, or excessive parenchymal stress/strain [lung overdistension caused by patient self-induced lung injury (P-SILI)] can all cause excessive inflammation. We discuss the heterogeneity of intrapulmonary distribution of W/D ratios. A W/D ∼6.5 has been identified as being critical for the transition to severe edema formation. Increasing Palv for W/D > 6.5, both trans-endothelial and trans-epithelial gradients favor filtration leading to alveolar flooding. Neither CT scan nor ultrasound can identify this initial level of lung fluid balance perturbation. A suggestion is put forward to identify a non-invasive tool to detect the earliest stages of perturbation of lung fluid balance before the condition becomes life-threatening.

Keywords: SARS-CoV-2, ARDS, edema, alveolar pressure, P-SILI, computational model

Introduction

Efficient gas diffusion in the air-blood barrier is only possible by strict control of extravascular water volume to prevent edema-induced tissue swelling and alveolar flooding. In normal lungs, the thickness of the air-blood barrier does not exceed ∼0.2 μm. Edema is prevented by an extremely low microvascular permeability and dynamic remodeling of the interstitial matrix (). The physiologic parameters controlling lung fluid balance are dynamic and change over the life span of individuals to ensure a healthy match of regional ventilation to the metabolic requirement.

This study merges the understanding of normal physiologic fluid balance control with the ramifications of what can occur when this control is lost. We will first review how a healthy lung can tightly control extravascular lung water by specific mechanical alterations to parenchymal structure that will efficiently minimize edema. Next, we will investigate how progressive loss of this anti-edemagenic control inevitably leads to severe edema. We present a detailed analysis of Starling pressure gradients sustaining flows across the endothelial and epithelial barriers. We stress the point that the heterogeneity in edema distribution allows us to distinguish between lung regions that can still provide control of fluid balance to allow gas exchanges and other regions that have lost this capacity because of breakage of the interstitial matrix. We correlate the Starling pressure gradients with the specific regional edema formation measured as the lung tissue wet-to-dry weight ratio (W/D). This study provides contribution to the understanding of acute lung injury pathophysiology and the role of mechanical ventilation in edema formation. In particular, this study is one of the first to discuss trans-endothelial and trans-epithelial flows as distinct events for a given lung distension pressure. It is hoped that this review might provide indications aimed at avoiding an unintentional ventilator-induced lung injury (VILI).

The Air-Blood Barrier and the Molecular Structure of the Interstitial Compartment

The air–blood barrier (ABB) represents the interface for gas exchanges; the capillary endothelium is in close apposition with the alveolar epithelium so that the thickness of ABB is as low as 0.3 μm and its surface is in the range of 100 m2 in the human lung ().

The ABB includes two portions: a thin side (Figure 1A) that accounts for more than 50% of alveolar surface that contains minimal interstitial space (), and a thick side (Figure 1B) that includes most of the parenchymal extra cellular matrix (ECM) and lymphatics. It has been suggested that the thick portion acts as a reservoir capacity where fluid filtered at the level of the thin portion might accumulate to be drained down a pressure gradient generated by lymphatics (; ).


Morphology of the air-blood barrier (ABB). (A) Thin portion of ABB showing the close apposition between alveolar epithelium (EP) and capillary endothelium (EN). PV is plasmalemmal vesicle (from ). (B) Microscopy image showing the ABB and its thin and thick portions. ECM, extra cellular matrix; cap, lung capillary; ic, interstitial cell (from ).

The special arrangement of the endothelial and epithelial cells is seen in Figure 2. Type-1 epithelial (Epi1) cells cover about 95% of the surface of each alveolus, with the rest being covered by globular Epi2 cells.


Scanning electron micrograph of the alveolar surface of a human lung showing protruding capillaries and two type II cells (Ep2) sitting in niches and characterized by a rim of microvilli. Small arrow points to cell body of a type I cell (Ep1) that covers several capillary meshes (yellow); the boundary of its cytoplasmic leaflet is marked by arrowheads outlining a small lip of the cell junction between adjoining cells (inset, compare Figure 1B). The surface area covered by this cytoplasmic leaflet is 1,300 mm2. Scale bar = 10 μm (from ); reprinted with permission of the American Thoracic Society.

The body of Epi1 cells forms a series of interconnected structures that envelop, through several stalks, approximately 40 capillaries. There are only about 40 Epi1 cells lining a single alveolus facing about 170 endothelial cells, so any Epi1 cell covers about four endothelial cells. An average volume of ∼1,700 μm3 of an Epi1 cell spreads over a surface area of ∼5,000 μm2, and allows for a thickness of as low as 0.3 μm. Such a low number results from the combination of low number of Epi1 cells and extended plasma membrane surface. On the whole, the overall surfaces of Epi1 and endothelial cells are comparable.

Two important functional features of ABB are the following: very strict control of water balance by minimizing fluid exchanges across the endothelial and epithelial barriers, and remarkable mechanical resistance to the increase in tension related to change in lung volumes. These two important features rely on the structure-function relationship between the epithelial and endothelial cells and the macromolecular structure of the interstitial compartment separating the epithelial and endothelial layers.

The structure of the interstitial compartment includes a mesh of collagen and elastic fibers whose main role is to provide mechanical support and elasticity (). These molecules are chemically very stable and resistant to proteolysis. Within the space between these molecules, there is a dense mesh of molecules, belonging to the proteoglycan family, whose main role is to exert a strict control on the amount of extravascular water that must be kept to a minimum. Microvascular permeability is controlled by the low molecular weight heparan-sulfate proteoglycan (HS-PG, 300–500 kDa) of the basement membrane and by small peptidoglycans of the glycocalyx (PDGL), normally assuring high resistivity of the paracellular route (). Large molecular weight chondroitin-sulfate proteoglycans (CS-PG > 1,000 kDa) bound to hyaluronan act as link proteins through low energy non-covalent bonds with other molecules and cells providing rigidity to the parenchymal mesh.

The Control of Extravascular Water Under Physiological Conditions

The hydraulic pressure (Pint) in lung interstitial compartment is in the sub-atmospheric range, averaging ∼10 cmH2O (), and a negative Pint value represents the fluid dynamic equilibrium between capillary filtration down a high resistance pathway (low microvascular permeability) and a lower resistance pathway represented by lymphatic drainage. The equilibrium is also favored by the transcapillary oncotic pressure gradient (favoring absorption) that exceeds the hydraulic gradient (favoring filtration) ().

Figure 3 presents the fluid exchange models for the thin the thick portions of the ABB, and the parameters defining the pressure gradients that sustain potential water and solute fluxes across the endothelium and the epithelium. Note that lymphatics are only present in the thick portion of the ABB.


Lung fluid compartments of the ABB and parameters governing fluid exchanges. Pc, Pint, and Pliqalv are capillary, interstitial, and alveolar liquid hydraulic pressure, respectively; Πc and Πint are capillary and interstitial oncotic pressure, respectively; σendo and σepi are the protein reflection coefficient of endothelium and epithelium, respectively; Palv is the alveolar pressure; Lp, A, Kfendo, and Kfepi are the hydraulic conductance, overall filtration surface, and endothelial and epithelial filtration coefficient, respectively. Lymphatic drainage (Jl) occurs from the thick portion of ABB where lymphatics are located.

Transcapillary and transepithelial water exchanges are governed by the Starling law where P and Π are the hydraulic and the colloid osmotic pressures across any two compartments. Water flow (Jv) is defined as:

Jv=Kf⋅[(P1-P2)-σ(Π1-Π2)]

(1)

where Kf (filtration coefficient) = Lp ⋅ A, with Lp being the hydraulic conductance, A the surface area available for flow, and [(P1−P2)−σ(Π1−Π2)] the Starling pressure gradient generating flow.

In this study, we will focus on the Starling pressure gradients, and based on experimentally measured values, will analyze how they are modified to cause severe perturbation in lung fluid balance. Relevance will also be given to the estimate of the effect of increasing alveolar pressure on these gradients, a point that, so far, has remained unexplored but of utmost importance in mechanical ventilation. In a companion study, the Starling pressure gradients presented in this study will be used to model the transcapillary, transepithelial, and lymphatic flows in physiological condition as well as in developing severe lung edema.

Our whole analysis considers W/D as the more precise and reliable index of the lung fluid balance that has been related to experimentally measured values of variables and coefficients appearing in Eq. 1. The validity of W/D as an index of water balance was confirmed by who reported its excellent correlation with albumin and total proteins collected from the bronchoalveolar lavage fluid, an index of derangement of fluid balance in experimental models of graded lung injury.

Table 1 reports the Starling pressure gradients in a healthy lung at end-expiration and at end- inspiration. End-expiration corresponds to functional residual capacity (FRC) ∼22% TLC in supine position, while end-inspiration corresponds to ∼32% TLC (). Water balance under physiological condition is defined by a lung wet weight/dry weight ratio (W/D) of ∼5 (). In Table 1 and from here on, positive values of a Starling gradient across the endothelium and the epithelium indicate fluid filtration into the interstitial space and the alveolar compartment, respectively; negative values of a Starling gradient indicate fluid clearance from these compartments.

TABLE 1

Trans-endothelial and trans-epithelial Starling pressure gradients at end-expiration (functional residual capacity, FRC) and end-inspiration under physiological conditions (referring to Point A in Figure 4).

Trans-endothelial

Trans-epithelial

End-expirationEnd-inspirationEnd-expirationEnd-inspirationPcap*99Pint**−10−24Pint**−10−24Pliq alv#∼ 0∼ 0σ end

0.850.85σ epi

0.850.85Πcap**26.826.8Πint**13.813.8Πint**13.813.8Πliq alv00γ11 ΔP 19 33 ΔP −10−24 σ⋅ΔΠ −11.0−11.0 σ⋅ΔΠ −11.7−11.7 Starling gradient 8.0 22.0 Starling gradient −21.7−35.7

Table 1 reports the expected values of hydraulic pressure for the capillary, interstitial, and alveolar fluids (Pcap, Pint, and Pliqalv, respectively) as well as those of oncotic pressure (Πcap, Πint, and Πliqalv, respectively). The value of Pliqalv, the pressure of the liquid phase coating the alveolar surface, was estimated from the equation Pliqalv=Palv-2γR, (). We considered Palv = 0 at end-inspiration and at end-expiration (FRC) during spontaneous breathing, and we assumed a physiological value for γ = 1 dynes/cm substantially unchanged up to 70% TLC (). We assumed an alveolar radius of ∼ 50 μm at TLC () and its decrease at FRC being proportional to (FRC/TLC)1/3 (equal to 0.6). Accordingly, given the low value of γ, the ratio 2γ/R = Pliqalv is ∼ 0 cmH2O. Clearly, the large change in trans-epithelial Starling gradient reflects the remarkable change in Pint.

Endothelial and epithelial protein reflection coefficients (σendo and σepi, respectively) are also reported. Hydraulic (ΔP) and oncotic (σΠP) pressure gradients and the total Starling pressure gradient are reported in bold. Concerning σ, it was experimentally derived at high flow rates as σ = 1 −ϕ (ϕ being the lymph/plasma protein partition coefficient). However, this condition might not provide a σ value corresponding to the physiological condition of very low flow rates. For both endothelium and epithelium, we assumed σ = 0.85 (), a higher value compared to those previously provided by . Furthermore, under healthy conditions, the epithelium is almost totally impermeable to proteins (), and water transport can only occur via coupled Na+ active absorption (). One report showed that epithelial monolayers generally have an electrical resistance that is an order of magnitude higher than that of endothelial monolayers and much lower solute diffusion permeability ().

Concerning the microvascular district, one should add the important notion that functional compartmentation has been described considering a “true” alveolar compartment and an extra-alveolar capillary compartment. The latter has higher Lp and lower surface area compared to the “true” alveolar district, which has a much lower Lp but an incredibly much higher surface. Definitely, the “true” alveolar compartment only contributes about 6% of total convective albumin flux recovered in the lung lymph (). Therefore, under physiological conditions, despite the existence of trans-endothelial and trans-epithelial pressure gradients shown in Table 1 (referring specifically to the “true” alveolar district), minimal fluxes occur thanks to low permeability coefficients. One shall consider that capillary surface area (A) might differ among humans, reflecting the individual extension of the alveolar capillary network that was found to vary by ∼3 fold based on the estimate of the capillary blood volume (Vc) ().

The Response to the Increase in Microvascular Filtration

Figure 4 shows how Pint varies with increasing water balance as expressed by the W/D ratio. Point A corresponds to the physiological condition, while Point B corresponds to the physiological response acting to buffer an increase in microvascular filtration in response to an edemagenic condition.


Relationship between interstitial hydraulic pressure (Pint) and wet-to-dry weight (W/D) ratio at end-expiration. Point A corresponds to physiological condition; point B to the “safety factor” (see text for explanation); point C corresponds to the absence of the “safety factor” reflecting the remarkable loss of integrity of the interstitial matrix (, ).

The latter may occur because of a variety of reasons, such as hyperventilation and increase in cardiac output on sustained exercise (e.g., marathon running) (). The lung is well-equipped to respond to increased microvascular filtration due to specific morpho-functional features of the interstitial tissue structure. Indeed, increased free water filtered in the interstitium is captured by hyaluronan to form gel, whose increase in steric hindrance causes a remarkable increase in Pint from −10 cmH2O (Figure 5, point A) to ∼ +5 cmH2O (point B) (). At point B, the W/D ratio does not exceed 5.5 (10% increase relative to the control value), reflecting low tissue compliance (∼0.5 ml.mmHg–1⋅100 g of wet weight–1) (). As long as the filtration coefficient and the protein reflection coefficient remain within physiological values, interstitial gel formation provides a “safety factor” against edema formation to face an increase in microvascular filtration. Indeed, the increase in interstitial pressure (see Eq. 1) prevents further filtration and may actually favor fluid re-absorption (see Paragraph 8 for estimate of actual Starling pressure gradients). The correlation between rigidity of the extracellular matrix and low microvascular permeability was confirmed in a micro-nano biomimetic system by growing endothelial and epithelial cell layers on opposite sides of a porous mesh mimicking the extracellular structure of the basal lamina in the lung. Varying the rigidity of the mesh, and using different concentrations of polycaprolactone with gelatine, it was found that effective barrier properties were actually increased by increasing the stiffness of the matrix ().


Left: time course of the recovery of fragments of proteoglycan families upon 12% O2 exposure (redrawn from ). Peptidoglycans (PDGLs) control the permeability of the glycocalyx; heparin-sulfate proteoglycans (HS-PGs) control the permeability of endothelial and epithelial cells; chondroitin-sulfate proteoglycans (CS-PGs) provide rigidity to the interstitial matrix. Right: relationship between loss of integrity of interstitial hyaluronan (a hydrophilic non-sulfated glycosaminoglycan) and increase in W/D ratio. Points A, B, and C correspond to those reported in Figure 4.

Respiratory mechanics was monitored by low-frequency forced oscillation technique (FOT) in closed-chest mechanically ventilated rats under conditions referring to points A and B (). The results suggested that the changes in reactance and resistance when shifting from A to B could reflect the changes in viscoelastic properties of the lung tissue, in the absence of the accumulation of extravascular fluid into the alveoli. It was, therefore, proposed that the estimate of lung mechanics with FOT might represent a non-invasive, potentially clinically useful tool to detect the earliest stages of perturbation of lung fluid balance before the condition becomes life-threatening. The next paragraph describes how the loss of safety factor (Figure 4, point C), due to fragmentation of the interstitial matrix structure, leads to a decrease in Pint to 0 cmH2O and to a critical increase in W/D ratio.

The Tissue Damage and the Critical Increase in W/D Ratio

The inflammation caused by a sterile (e.g., severe hypoxia, hyperoxia, surgery, excessive parenchymal stress/strain) or bacterial/viral mechanism may trigger the fragmentation of the macromolecular architecture of the interstitial compartment, involving the whole proteoglycan family. Figure 5 (left) shows, as an example, the time course of the recovery of fragments of proteoglycan families on 12% O2 exposure (). Over time, fragment recovery occurs at a greater rate for PDGL and HS-PG, compared to CS-PG. The loss of integrity of the native architecture of the proteoglycan family of the interstitial matrix leads to a combination of two effects: (i) increase in microvascular permeability, which weakens the restriction to fluid leak, and (ii) increase in tissue compliance that brings Pint back to 0 cmH2O (Figure 4, point C, W/D ∼7.5). As a consequence, the “safety factor” is abolished and the corresponding increase in W/D ratio reflects the increase in filtration rate leading to the development of edema. The right panel of Figure 5 shows the negative correlation between the loss of integrity of the interstitial matrix and the increase in W/D. With 50% fragmentation of native hyaluronan, W/D increases by up to ∼ 7.5, a frankly edematous state (; ).

Differences in the sequence of a fragmentation of proteoglycans may be demonstrated among various models of experimental pulmonary edema (; ). Thus, there may be a variable time-dependent contribution to edema formation due to the increase in microvascular permeability (due to the fragmentation of HS-PG and PGDL) and/or increase in tissue compliance (reflecting the fragmentation of CS-PG). The inflammatory-dependent activation of proteases (MMP-2 and MMP-9) contributes to proteoglycan fragmentation (). Heparan-sulfate disassembly has been reported by recent findings of HA exudates in the alveolar spaces of the lungs of patients with coronavirus disease-2019 (COVID-19) ().

It is noteworthy to consider the difference in timing between the phase of fragmentation of the interstitial mesh (3–6 h) and the immunity response reported for patients with COVID-19 that develops with a much slower kinetics during the first week after infection (; ).

Causes of Lesion of the Air-Blood Barrier

Severe Acute Respiratory Syndrome Coronavirus-2

Sepsis is due to lung lesions (). Concerning the kinetics of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a tempting hypothesis is that the entrance of virus into the ABB might resemble that of engineered nanoparticles (NPs) delivered through the airways for therapy. Findings highlight the intimate connections between viruses and NP with host lipid interactions. Both viruses and NPs could exploit dual entry, namely, crossing the plasma membrane or uptake via endosomes. Human ACE2-binding interface tends to have a predominantly negative electrostatic potential, allowing interaction with the SARS-CoV-2 S protein (). It takes less than 1 h for NPs to move into the lung interstitial space and reach the circulatory system (). Recent data suggest that heparan-sulfate proteoglycan on cell surface facilitates the attachment of SARS-CoV-2 particles to the cell surface to promote cell entry (). In particular, it was shown that SARS-CoV-2 spike protein interacts with both heparan-sulfate and the binding domain of ACE2 (). Vascular and thrombotic complications, such as symptomatic acute pulmonary embolism, deep-vein thrombosis, ischaemic stroke, myocardial infarction, and systemic arterial embolism, have been reported in severe COVID-19 cases ().

Reactive Oxygen Species

Molecular oxygen is activated in either hyperoxia or hypoxia into reactive oxygen species (ROS). Effective antioxidant defenses counteract the reactivity of ROS. However, the overwhelming production of ROS coupled with their insufficient scavenging by endogenous antioxidants will lead to tissue damage and cell death (). ROS are implicated in the increase in alveolar permeability (; ). It was found that exposure to 100% O2 increased alveolar epithelium permeability similar to that caused by the alloxan model of lung edema, and that this occurred before the onset of interstitial or alveolar edema (, ).

Hyperoxia also causes damage to endothelial cells () and tissue structure (; ) because of increased production of reactive oxygen species (ROS) at mitochondrial level ().

The risk of ROS-dependent lung injury is reported to occur at FIO2 > 0.7, and may worsen at FIO2 > 0.8 for prolonged exposure. To limit the exposure to high levels of FIO2, there is a recommendation by ARDS Network to target PaO2 levels between 55 and 80 mmHg in mechanically ventilated patients. Milder levels of hyperoxemia would be supported by data suggesting that PaO2 > 80 mmHg is associated with worse clinical outcomes at all levels of acute respiratory distress syndrome severity ().

Type-1 epithelial (Epi1) cells could be completely destroyed by hyperoxia (), so, after a few days of hyperoxia exposure, the whole alveolar surface would be found to be lined only by cuboidal Epi2 cells (; ), a finding also reported for oxygen poisoning in human lung (). The role of Epi2 cells was interpreted as that of regeneration of new Epi1 cells (; ; ). Neo-formed Epi1 cells appear able to branch and form at least four or even more lining units on endothelial cells (so called “epithelial plate”) (). Ischemia-reperfusion injury (a primary graft dysfunction) is a form of high-permeability pulmonary edema due to endothelial lesion ().

Lung Overdistension

Lung overdistension is a major cause of tissue lesion. Going from low to high transpulmonary pressure causes an increase in fluid filtration rate (). Inflating the lungs to total capacity is found to cause free solute movement across the lung epithelium because of larger pore radii. Furthermore, decreasing lung volume does not produce a smaller pore radius that either remains the same or becomes larger. This phenomenon is interpreted as depending on permanent lung lesion (). Furthermore, data by suggest that acute lung distension at Palv = 40 may cause epithelial albumin leak but not alveolar flooding: the interpretation of this result is that, upon short exposure to considerable lung distension, no time is given for remarkable matrix fragmentation. A 5-fold increase in Jv over 6 h with step change of Palv from 10 to 20 cmH2O (; ). W/D was found to increase from 6.63 to 7.45 over 2 h with Palv up at 48 cmH2O (); this same study reported an increase in albumin concentration in bronchoalveolar lavage fluid by up to 250 mg/ml.

Other data report a significant increase in endothelial Kf for alveolar pressure exceeding 42 cmH2O (). A remarkable increase in Lp was found over 8h due to increased size of pores, and thus increase in filtration surface area, for only 10% increase in strain (lung-on-a-chip microdevice model, ). Experimental models of an injurious ventilatory strategy were found to predispose to subsequent bacteremia and associated impaired host defense ().

The Alveolar Folding/Unfolding Zone

The specific topology of Epi1 cells is such that they are far from being flat (see Figure 2; ). Furthermore, these cells present numerous pleats on their surface, as deduced by following the profile of the basement membrane, that are subjected to the cyclic folding/unfolding process on changing lung volume (). Based on data from electron microscopy, unfolding was found to be completed in healthy lung upon reaching a transpulmonary pressure ∼ 15 cmH2O, corresponding to ∼75–80% Vital Capacity (VC), (with a surface tension not exceeding 5–7 dynes/cm, ). The folding-unfolding process was confirmed also for the human lung by estimating the increase in lung diffusion capacity on increasing lung volumes from FRC up to 100% VC. It was found that the increase in diffusion capacity could be modeled according to the increase of the ratio between the alveolar surface and thickness of the air-blood barrier (Salv/τ) ().

The result was that the increase in diffusion capacity was proportional to the increase of Salv up to a lung volume of ∼80% VC, at which the “reserve” surface of the unfolding pleats was completed. Above this volume, the diffusion capacity was proportional to the decrease in τ. It was, therefore, concluded that above ∼80% VC, thinning of septa occurred because of direct tissue stretching. Further data confirm that in the healthy lung, increasing volume might occur without much strain of the Epi1 cell surface thanks to the “reserve” surface of the pleats, and that direct stretching of the septa occurs with increasing strain above 75–80% VC (). Figure 6 shows the volume-pressure curve of the lung, chest wall, and respiratory system in a healthy subject to show: (i) the FRC (red dot) and (ii) the percent of lung distention (65–80% of VC) and corresponding alveolar pressure (15–25 cmH2O) upon approaching the saturation of the alveolar unfolding process (shaded area).


Volume-pressure curve of the lung, chest wall, and total respiratory system (Plung, Pcw, Prs, respectively) to identify the relative lung distention at functional residual capacity (FRC) (Palv = 5 cmH2O, red arrow) and completion of the alveolar unfolding process occurring in the range Palv 15–25 cmH2O (blue arrows), corresponding to ∼65–80% Vital Capacity (VC, shaded area).

In the supine subject, FRC is decreased down to about 22% () so, assuming that the saturation of the unfolding process also occurs at about 80% of lung distension, the range of the folding/unfolding process is increased.

One may attempt to comment on the clinical outcome from mechanically ventilated patients with ARDS considering the ventilatory strategy with specific relation to the folding/unfolding zone. One can, therefore, pose the question of how a ventilatory strategy implying a cycling involvement of the folding/unfolding zone might have an impact on lung function. reported 50% increase of death when oscillating lung volume across 70% lung distension, compared to a strategy of ventilation set either above or kept below 70% VC. The occurrence of repetitive recruitment and de-recruitment during mechanical ventilation of a diseased lung (bleomycin treatment or surfactant deactivation by Tween 20 detergent) was shown to cause remarkable alveolar instability with atelectasis in some alveoli and overdistention of adjacent ones, referred to as atelectrauma and volutrauma, respectively (; ; ; ; ; ; ; ; ). Accordingly, it was hypothesized that these maneuvers set a vicious cycle by which the alveolar damage progresses within the lung from atelectatic to adjacent non-atelectatic lung regions through mechanical interdependence. Data from also prove that the sequence of cyclic folding/unfolding leads to a remarkable increase in microvascular permeability due to progressive increase in endothelial lesions (rich-get-richer scheme). It appears, therefore, that a ventilatory strategy implying a cyclic folding/unfolding process favors tissue damage.

The Rest Lung Approach (RLA) () and Open Lung Approach (OLA) () are the two main protective ventilation strategies being used currently. The RLA assumes the two-compartment ARDS model with collapsed, edematous, and unstable tissue in the dependent portion of the lung and small volume of normal tissue in the non-dependent portion of the lung (). Using a low tidal volume and plateau pressure, the RLA is designed to “Rest” the dependent injured lung tissue by keeping it completely out of the ventilation cycle and “Protect” the small amount of normal lung tissue from overdistension. The OLA assumes that lung protection is better afforded by completely opening the collapsed and edema-filled tissue using higher PEEP with and without recruitment maneuvers. Unfortunately, these protective ventilation strategies have not been effective in further lowering mortality over the last 20 years, suggesting the need for novel protective ventilation strategies to be tested (; ).

Airway pressure release ventilation (APRV), set and adjusted using the Time-Controlled Adaptive Ventilation (TCAV™) method, sets ventilator pressure above the folding/unfolding zone and uses a very brief release phase, personalized to changes in lung collapse time constants, that does not give the tissue sufficient time to fold. The TCAV™ method has been reported to be protective as compared to cyclic ventilation crossing the folding/unfolding zone (, ,; ,, ). A reduced microstrain has been reported for a ventilation implying alveolar pressure above the folding/unfolding zone (PEEP 16–24 cmH2O) and a short time at low pressure () using the TCAV™ method. Data from indicated that APRV with Palv 21 cmH2O was more efficient than Pressure Support Ventilation (PSV) set at PEEP 10 with Ppeak 23 cmH2O that implies cycling crossing of the folding/unfolding zone. In a bleomycin injury lung model, tissue damage could be moderated by ventilation at PEEP = 20 cmH2O, where unfolding is almost completed (). Finally, a multilevel analysis of data from 3,562 patients with ARDS revealed that the least risk of death in the hospital correlated with a ventilatory strategy at alveolar pressure high enough to avoid a wide range of cycling crossing of the folding/unfolding zone (). It has also been shown that in preterm infants (≤32 weeks of gestation), alveolar recruitment is more efficient with continuous than with discontinuous CPAP (∼5 cmH2O), which normalizes the FRC volume ().

The TCAV™ method, which is a novel Stabilizing the Lung Approach (SLA), was developed based on the fact that cyclic recruitment-derecruitment in surfactant-deprived lungs leads to a significant degree of alveolar instability (). The goals of the SLA are to very quickly stabilize alveoli and prevent folding/unfolding injury. Once stable, the collapsed tissue can be gradually reopened over an extended period of time (hours or days). Using a very brief release phase, directed by changes in lung collapse time constants, has been shown to very quickly stabilize alveoli. The extended inspiratory time, known as the continuous positive airway pressure (CPAP) phase, gradually opens the collapsed lung tissue over an extended period of time (, ,; ,). The SLA may facilitate edema re-adsorption and reduce mechanical damage to endothelial and epithelial cells, as compared with the RLA and RLA methods (,). The possible mechanisms for the efficacy the TCAV™s methods in reducing edema accumulation and expediting edema removal are based on the following: (i) very quickly avoiding the cycling folding/unfolding of alveolar walls using a very brief release phase, (ii) the rapid lung inspiration at the end of the release phase gradually recruits alveoli via a “ratchet” mechanism similar to the way the newborn opens their collapsed fluid-filled lungs at birth (), (iii) stabilizing and then progressively opening alveoli will maintain normal surfactant protein concentration.

Patient-Self-Inflicted Lung Injury

The case of the patient-self-inflicted lung injury (P-SILI) deserves a particular consideration. Evidence has been provided for high tidal volumes developed by patients receiving non-invasive respiratory support based on increasing alveolar pressure. Furthermore, a correlation was found between diaphragmatic swings and risk for P-SILI due to lung overdistension (; ). The correlation between lung overdistension and lung lesion can be easily accepted (). However, the understanding of potential “exaggerated” diaphragm contractions has remained elusive. Perturbation in respiratory drive has been invoked by reviewing some possible reflex mechanisms of neural control of breathing (; ). We wish to consider a so far overlooked physiological feature of the diaphragm as a pressure generator. For a given neural drive, diaphragmatic contraction appears to be quite stable and cannot be modified once started, as the diaphragm is almost void of proprioceptors (). From a mechanical standpoint, the question is: what is the outcome of diaphragmatic contraction when the diaphragm is facing a change in mechanical load? If the load is increased (e.g., adding external respiratory elastance), the inspired volume will decrease (). In fact, no “load compensating reflex” is present, as no proprioceptor afferent input is present. The opposite case is now that of removing part of the elastance that the diaphragm faces during its contraction. This case occurs by increasing alveolar pressure; in fact, increasing alveolar pressure might remove part or all of lung elastance. The result is an increase in lung volume, since the first breath gives rise to over distension and lung injury (). One could estimate that by removing the elastance roughly equivalent to that of the lung, the increase in inspiratory volume would amount to ∼150–200% of the control value. Such increase is expected to vary among patients, as lung elastance is related with the number of ventilated units, being higher with increasing alveolar flooding. Neuromuscular blockers obviously contrast this phenomenon (; ). External (inspiratory) intercostal muscles do exhibit proprioceptors innervation: accordingly, they might increase their contraction on adding external elastance (“load compensating reflex”) but would be silent on increasing alveolar pressure (thus, the decrease in elastance remains unopposed). One could consider that a patient exposed to increased alveolar pressure has to perform active expiration that is normally passively relying on the elastic recoil of the respiratory system. If the above interpretation is valid, it would not be paradoxical to retain the P-SILI acronym, but the expansion should read Patient-Strategy Induced Lung Injury!

Factors Preventing the Development of Edema: Interstitial Capacitance, Lymphatic Flow, and Vasomotion

The first line of defense against increased microvascular filtration is fluid accumulation in the thick portion of the air blood barrier. Up to W/D ∼5.5, some fluid accumulates in the endothelial cells whose swelling may account for ∼45% of their control volume, while ∼85% of filtered fluid accumulates in the thick portion of the air-blood barrier () where lymphatics are present. This morphological arrangement corresponds to a model of a relatively rigid initial compartment (the thin portion of the ABB) that communicates by a relatively high-resistance pathway to a larger downstream capacity (the thick portion of the ABB) ().

Human lymphatics extend deep inside the pulmonary lobule; indeed, a peripheral distribution of lymphatics (defined as interstitial lymphatics) was described down to the peri-microvascular district near the alveolar, the alveolar ducts, and the interalveolar septa (; ; ; ). These lymphatics converge into a central compartment, becoming large conducting vessels associated with the broncho-vascular bundle ().

Under baseline conditions, lymph flow rate is 0.063 ml/min/100 g (), and only about 4% of this value corresponds to alveolar fluid clearance. The latter corresponds to the transepithelial active sodium transport. If the “safety factor” is intact, most fluid clearance occurs via Starling-depended fluid re-absorption () back into the capillaries, with only a minor fraction (∼18%) via lymphatics ().

Lymphatics can increase flow, and thus, provide a passive negative-feedback control loop to offset an increase in extravascular volume (). Interestingly, lymph flow was found to be proportional to the rate of increase in lung weight that is directly related to the microvascular filtration rate (). Interstitial fluid ought to percolate through the interstitium down a pressure gradient generated by lymphatics themselves that were shown to generate a subatmospheric pressure compatible with the measured value of Pint (). Redistribution of fluid downstream from filtration sites was modeled by relating the increase in lymphatic flow in response to increase in filtration rate as a function of interstitial fluid resistance (). These authors found that, for interstitial compliance in the physiological range (intact matrix), a 3-fold increase in lymphatic flow could balance the increased filtration rate by holding interstitial pressure at about 2 cmH2O. When interstitial hydration increases, matrix fragmentation would actually decrease tissue resistance for fluid flux toward lymphatics, in line with the model developed by . In case of experimental lung lesion, lung lymph flow was found to increase by ∼8- to 10-fold ().

A recent microfluidic study revealed considerable differences among lung regions concerning interstitial fluid dynamics from capillary filtration sites, through the porosity of the interstitium, and into the lymphatic network. This conclusion came about by combining specific lymphatic immunohistochemistry with high-resolution X-ray computed tomography and finite-element mathematical modeling that identified differences related to the functional interaction between tissue mechanical properties and the action of the lymphatic pump (). Lymphatic clearance of alveolar fluid can only occur with an epithelial barrier lesion, as confirmed by data from hyperoxia (; ) and ventilator-induced lung injury lesion models ().

Mechanical ventilation and positive end-expiratory pressure (PEEP) impede lung lymph flow by increased intrathoracic pressure and increased central venous pressure. PEEP may, thus, enhance edema formation of the lung (). Obviously, when lung W/D increases, the lymphatic flow cannot balance the flow of filtration. This occurs in case of severe endothelial and epithelial lesions. Alveolar flooding occurs when the increase in lung W/D exceeds 35% of baseline (), corresponding to ∼6.25.

Figure 7A shows the distribution of extravascular interstitial and alveolar water upon increasing W/D by up to 10, normalized to 1 kg lung () and assuming ∼35% increase in interstitial water (). Figure 7B provides images of the morphological changes of the lung from control (left) to a transition phase implying fluid accumulation in the interstitial space (center) and alveolar flooding (right). On mechanical ground, alveolar flooding implies a progressive loss of alveolar expandable units, and correspondingly, a decrease in lung compliance.


(A) Distribution of extravascular lung water to the interstitial (Wint) and alveolar (Walv) compartment on increasing W/D. (B) Morphological changes of the lung from control (left) to a transition phase with fluid accumulation in the interstitial space (center) and alveolar flooding (right). c, pulmonary capillary (redrawn from ).

Based on the pressure generating a trans-endothelial flow, a morphological-based model was developed to describe the interaction between control of extravascular lung water and capillary perfusion under edemagenic conditions (). The model focused in particular on the fact that the increase in Pint, besides buffering and even reversing the transcapillary Starling gradient, leads to capillary de-recruitment because of the compressive effect of positive interstitial pressure; the resultant decrease in exchange surface area is a potent factor to decrease Kf. Data on humans confirmed blood flow limitation in edemagenic lung regions, despite the administration of a vasodilator agent ().

Precapillary vasoconstriction is a further strong anti-edemagenic mechanism (; ). In fact, redirection of blood flow from edematous to normal lung regions has been correlated with the increase in Pint in the former as well as with the corresponding precapillary vasoconstriction and vasodilation in the two regions, respectively (). Interestingly, inter-individual differences have been documented concerning capillary recruitment/de-recruitment under edemagenic conditions, such as exercise or exposure to hypoxia; in particular, capillary de-recruitment has been interpreted as individual proneness to develop lung edema (; ,). In general, a greater density of pulmonary capillaries favors oxygen diffusion-transport at the alveolar level (,); however, it involves a greater risk factor of developing lung edema because of greater capillary surface for microvascular filtration (). It is tempting to consider pulmonary hypertension, as observed under strong edemagenic conditions (hypoxia), as the consequence of precapillary vasoconstriction represents a powerful means to limit microvascular filtration (; ).

There is an interesting report concerning the preventive effect of gadolinium in models of lung lesions caused by Palv at ∼30 cmH2O that induces a ∼2-fold increase in Kf. The data suggest that gadolinium prevents increased microvascular permeability caused by stretch-activated cation channel-induced increases in intracellular calcium concentration (). Another potentially edema-preventive strategy considers the role of NADPH oxidase type 2 (NOX2) that is a major source of ROS in the lung. Pre-treatment with an inhibitor of NOX2 () was hypothesized as preventive of the secondary inflammatory component. A further study suggests that dietary antioxidants could represent a potential treatment for oxidative stress lung injury in patients on mechanical ventilation ().

Modeling the Starling Gradients in the Progression Toward Severe Lung Edema

Table 2 summarizes the database to compare the Starling gradients as edema progresses from point B (“safety factor”) to point C. When the “safety factor” is on, trans-endothelial Starling gradients are decreased; in particular some fluid reabsorption may actually occur across the capillary wall at end-expiration. This last point is confirmed by who, adopting an experimental model that limited the increase of W/D at ∼6, found that ∼42% of water filtered into the interstitium was cleared by reabsorption into the pulmonary capillaries. At point B, considering γ is still equal to 1 dynes/cm, negative values of Starling gradients across the epithelium prevent any risk of alveolar flooding.

TABLE 2

Trans-endothelial and trans-epithelial Starling pressure gradients at end-expiration, with “safety factor” (point B in Figure 4) and after some degree of matrix fragmentation (point C in Figure 4).

Trans-endothelial

Trans-epithelial

Point B (W/D = 5.5)Point C (W/D∼7.5)Point B (W/D = 5.5)Point C (W/D∼7.5)Pcap*99Pint**5.70Pint**5.70Pliq alv#∼0−17σ end

0.850.5σ epi

0.850.5Πcap**26.814.7Πint**13.89.3Πint**13.89.3Πliq alv05γ125 ΔP 4 9 ΔP 5.7 17 σΔΠ −11.0 0.0 σΔΠ −11.7−2.15 Starling gradient −7.0 6.3 Starling gradient −6.0 14.85

We ignore the value of surface tension at point C (W/D ∼7.5), as well as the corresponding value of Pliqalv. Assuming that γ value increased by up to 25 dyne/cm at point C (due to both surfactant dilution and de-activation), Pliqalv would decrease to −17 cmH2O, so the resultant Starling trans-epithelial pressure gradient would potentially cause alveolar flooding. Modeling the increase in γ between 20 and 40 dynes/cm would only slightly change the result confirming that a W/D in the range 6.5–7 represents the critical threshold for alveolar flooding.

In Figure 8, we modeled the (A) trans-endothelial and (B) trans-epithelial Starling gradients on increasing W/D, in relation to the corresponding values of interstitial pressure (Pint), with Palv = 0 cmH2O.


Modeling of (A) trans-endothelial and (B) trans-epithelial Starling pressure gradients (solid line) on increasing W/D, based on experimentally measured values of interstitial pressure (Pint, dashed line), with Palv = 0 cmH2O. Points A, B, and C as from Figure 4.

With the “safety factor” on (point B), both trans-endothelial and trans-epithelial Starling gradients promote fluid reabsorption, in line with data from , . The critical factor leading to alveolar flooding is the development of a remarkably increasing negativity of Pliqalv as a consequence of the progressive increase in surface tension (γ) due to surfactant de-activation. We assumed an increase in γ from 1 to 25 dynes/cm for W/D > 6.5 (see Table 2).

Changes in Starling gradients and permeability parameters may be combined differently within the whole lung. In fact, the available experimental evidence confirms the heterogeneity in both regional lung fluid accumulation and perfusion under edemagenic conditions (). Basal lung regions are, in general, more exposed to edema because of greater blood perfusion, implying higher capillary Kf (). Alveolar flooding was found to occur in a quite non-homogeneous fashion revealing considerable regional differences ().

Figure 9 reports the estimated Starling pressure gradients at the (A) endothelial and (B) epithelial levels with increasing alveolar pressure of up to 25 cmH2O, as a function of W/D. We modeled the Starling pressure gradients on increasing W/D by increasing surface tension values from 1 to 40 dynes/cm. For W/D in the physiological range (5–6.5), the increase in Palv shifts the trans-endothelial gradients toward filtration, and on the opposite, the trans-epithelial toward alveolar re-absorption. Both effects tend to wane as W/D increases. Thus, in the W/D range of 5–6.5, the increase in Palv causes capillary filtration and alveolar clearance; accordingly, lymphatics have to cope with both flows. For W/D > 6.5, both trans-endothelial and trans-epithelial gradients favor filtration, leading to alveolar flooding. Note that for W/D > 6.5, the Starling pressure gradients, referring to different Palv, overlap, reflecting the fact that when the proteoglycan matrix is disrupted, the increase in Palv impacts equally on the increase in capillary pressure, interstitial pressure (), and Pliqalv ().


Estimated Starling pressure gradients at (A) endothelial and (B) epithelial levels on increasing alveolar pressure by up to 25 cmH2O, and on varying W/D from 5 to 9. Points A, B, and C refer to those in Figure 4.

The graphs in Figure 9 may be considered either as representing the Starling pressure-dependent course of developing edema, and as representing the regional differences in water balance within the lung. Indeed, novel CT imaging methods (, ) showed that aerated and non-aerated lung regions were diffusely intermingled. The erratic distribution of edema can be justified by the heterogeneous susceptibility to edema formation at alveolar level that was attributed to local differences in microvascular permeability possibly dependent upon alveolar morphology, as suggested by a novel lung imaging technique under experimental edemagenic conditions (). Heterogeneity in alveolar mechanics and fluid dynamics is confirmed by data from who generated VILI in mice ventilated with 50 cycles/min from FRC up to a plateau pressure of 37.5 cmH2O. Studying the alveolar de-recruitability on decreasing Palv, three alveolar phenotypes were described as a consequence of VILI: (1) flooded alveoli that cannot be recruited at any pressure, (2) unstable alveoli that are open at high pressures but readily collapse as pressure is reduced, and (3) relatively normal alveoli that remain open at low pressures.

An important relationship exists during cyclic mechanical ventilation between peak airway pressure (Ppeak) and positive end-expiratory pressure (PEEP). The data in Figure 9 suggest that the trans-endothelial filtration gradient increases with increasing Ppeak and PEEP. Conversely, no risk of alveolar flooding occurs for W/D < ∼6.5, as trans-epithelial gradients are in favor of fluid absorption. This may be partially balanced by a decrease in filtration surface as a consequence of a decrease in overall capillary blood volume (). Blood flow is also temporarily reduced, being proportional to the decrease in the difference between pulmonary artery and alveolar pressure. Lymphatic drainage can increase in this situation to maintain lung fluid balance. However, the time evolution of this situation should be regarded in terms of increase in W/D ratio as related to the progression of the fragmentation of the interstitial matrix (Figure 5).

The TCAV™ method, if applied pre-emptively before the development of severe lung injury, has been shown to prevent collapse of the acutely injury lung, maintaining a fully open lung, and if applied following the development of severe lung injury, will rapidly stabilize alveoli even with fast collapse time constants. If the ventilation strategy can put a “cast” within the acutely injured lung, much like putting a cast on a broken arm, the mechanisms of VILI-induced edema generation would be eliminated ().

One shall note that edema clearance in experimental models of ARDS can only occur in lung regions where W/D ratio does not exceed 6.5–7, as only in these regions the Starling gradients allow fluid reabsorption (see Figure 9). The presence of these regions can justify the observed average decrease in W/D ratio for the whole lung from about from ∼9 to ∼7; the latter value still corresponds to severe edema (; ; ,; ,, ).

Time Constant of Developing Severe Alveolar Edema

The development of lung edema depends upon various combination of an increase in Lp and in A as well as a decrease in σ, involving both the endothelium and the epithelium. Increase in capillary pressure and lung overdistension were shown to cause damage to the endothelial and epithelial barriers (). The critical phase of edema pivots around a W/D of ∼ 6–6.25. We hypothesize that for W/D to exceed 6, capillary filtration should occur down this still low-pressure gradient via increase in Lp and decrease in σ acting over a progressively larger portion of the alveolar compartment surface area, which may cause matrix fragmentation. Consider that the Lp of the “true” alveolar compartment is physiologically 20 times lower than that of the extra-alveolar compartment () while the capillary surface area is in the order of 70 m2 on a morphological basis. We suggest that a W/D ∼ 6.5 is the likely threshold, above which fluid will seep from capillary to alveoli down a small driving pressure gradient acting over a large surface of damaged air-blood barrier.

An exponential increase in lung weight (above a W/D of ∼ 6) has been modeled with a relatively short time constant (∼4 min) by moderate increase in either Lp or decrease in σ (). Similar time constants were found for the exponential increase in lung weight in response to a step increase in venous pressure (). The above hypothesis is strengthened by the finding that a >3-fold increase in microvascular filtration already causes an increase in trans-capillary convective transport of proteins compared to either diffusive or vesicular transport, suggesting lowering of the σ value (). Other data predict that a 50% increase in lung water may occur within 45 min after a step increase in left atrial pressure (2–14 cmH2O) and pulmonary artery pressure (13–22 cmH2O) ().

The Way to Recovery

A good model to explain the clearance of alveolar edema is the one proposed in full-term newborns (). Alveolar fluid clearance occurs down a two-step coupled mechanism: (1) epithelial water absorption via Na+-dependent transport and (2) Starling-dependent capillary re-absorption. Note that fluid reabsorption into lung capillaries is a self-limited mechanism due to increase in the colloid osmotic pressure at the interstitial end of the glycocalyx generated by protein accumulation preventing further absorption (; ; ). A recent report () shows that the transition from fluid-filled to aerated lungs in full-term newborns is accomplished using ventilation patterns characterized by a rapid high-peak inspiratory flow to “ratchet” open collapsed and flooded airway. The collapse of these newly recruited airways during expiration was minimized by partially closing the glottis to keep the lung pressurized. Thus, the inspiratory phase allows for rapid lung aeration extending from the central to distal lung portions; the expiratory phase maintains alveolar pressure allowing for fluid clearance. Maintaining a pressurized lung during expiration in a lung with low permeability of the epithelium and low compliance of the interstitial matrix results in an increase in interstitial pressure (as at point B) generating a trans-endothelial absorption via the Starling gradient. These two features are incompletely developed in preterm lung, and therefore, hinder alveolar fluid reabsorption (). An intact epithelial barrier allows Na+-dependent alveolar fluid reabsorption. provided the first evidence in humans to support the hypothesis that active ion transport across the alveolar epithelial barrier is the primary mechanism for the clearance of edema fluid. Na+ transport across the distal airway epithelium is the main determinant of alveolar fluid clearance, as demonstrated in several different species, such as the human lung (). With an intact epithelium, the clearance of alveolar fluid is rapid in patients with severe hydrostatic edema (). In contrast, in the majority of patients with acute lung injury, alveolar fluid clearance is impaired by reduced Na+ absorption ().

Controversies regarding the optimal mechanical ventilation strategy in patients with severe edema centers around the maintenance of alveolar pressure that favors fluid clearance and avoids the complication of volutrauma and atelectrauma. To favor alveolar fluid re-absorption in experimental edema models, the ventilatory strategy should allow to decrease W/D below 6.5, a cut-off suggesting restoration of control of lung fluid balance (Figures 8, ​9).

The re-deposition of an interstitial macromolecular matrix assuring low microvascular permeability and low interstitial tissue compliance appears critical for the control of lung fluid balance, since this would re-establish a “safety factor.” Most endothelial but not epithelial cells appear to be involved in the mechano-transduction signaling process in response to edemagenic conditions () that influence a specific cascade of cellular events aiming at remodeling of matrix macromolecules (, ; ). There are indications that post-infection activation of fibroblast does not allow the re-establishment of a matrix composition similar to the native composition (). In particular, the activation of fibroblast impacts hyaluronan synthase that controls the deposition of bundles of hyaluronan that actually represents the fibrotic response to recovery. In the presence of hyaluronan fragments during the early phase of lung injury, the balance between hyaluronan synthase isoforms and hyaluronidases plays an important role in the pathogenesis of lung fibrosis (). Recent data suggest that hyaluronan synthesis occurs in a matter of days ().

Conclusion

Although the sequence of events leading to severe lung edema have been delineated, at this point, there remains a wide gap in our knowledge of how to prevent the loss of lung fluid balance when W/D > 6 and the critical role of properly set mechanical ventilation. The data from this analysis support the contention that in diseased portions of the lungs (W/D > >6.5) the mechanisms necessary to clear edema fluid have been lost. Since the distribution of edema is heterogeneous by nature, in the lung portions where W/D < 6.5, the control of lung fluid balance is only possible when the built-in safety factors, intact matrix, interstitial capacity, and lymphatics not yet saturated, are still functional. Once both barriers (endothelium and epithelium) are breeched, and built-in safety components (capacity reservoirs and lymph flow) are saturated, massive flooding occurs. These considerations may help to “debug” the controversies concerning the outcome of various experimental models of lung lesion or clinical outcome in patients. Comparing data from different ventilatory strategies appears difficult, as these are highly influenced by the number of alveolar units allowing fluid clearance that cannot be directly measured. Reported values for W/D of the whole lung to validate ventilatory strategies aimed at facilitating edema re-adsorption, reducing mechanical damage, and preventing further increase in permeability never fell below 6.8 (see Paragraph 8). So far, neither CT scan nor ultrasound has been correlated to the corresponding regional values of W/D ratios. It would be useful to identify a non-invasive tool to detect the earliest stages of perturbation in lung fluid balance before the condition becomes life-threatening. Ventilatory support strategies, during either spontaneous breathing or mechanical ventilation, should carefully balance factors that can harm functioning alveolar units. Aiming at high oxygen saturation at the expense of alveolar hyperoxia should also be considered (see Paragraph 6.2). The clinical problem appears to be that of avoiding damage to the alveolar units that still retain gas diffusion-transport function. This certainly represents a critical question considering the severe complication of alveolar instability generated by cyclic recruitment-derecruitment in edematous lung regions (; ; ). The impact of positive airway pressure is complex for many reasons, considering in particular that an opposite flow may occur, depending on alveolar pressure, across the endothelium and the epithelium. A ventilation strategy that would keep the acutely injured lung open and stable would theoretically be optimal at minimizing pulmonary edema accumulation. The critical issue remains to be minimizing tissue damage caused by lung overdistension, and at the same time, avoiding tissue injury by cyclic folding/unfolding.

Author Contributions

EB, JG, GN, and GM joined their competences to complete the study. GM and EB conceived the work. FR and GS contributed to the computational part. All authors contributed to the article and approved the submitted version.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Footnotes

Funding

This study was partially funded by the NIH grant number HL136141. Funding for the Nieman lab was provided by NIH grant number R01HL142702 and Department of Defense grant number W81XWH-20-1-0696.

References

• Acute Respiratory Distress Syndrome Network, Brower R. G., Matthay M. A., Morris A., Schoenfeld D., Thompson B. T., et al. (2000). Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N. Engl. J. Med. 3421301–1308. 10.1056/NEJM200005043421801 [PubMed] [CrossRef] [Google Scholar]
• Adamson I. Y., Bowden D. H. (1974). The type 2 cell as progenitor of alveolar epithelial regeneration. A cytodynamic study in mice after exposure to oxygen. Lab. Invest. 3035–42. [PubMed] [Google Scholar]
• Aggarwal N. R., Brower R. G., Hager D. N., Thompson B. T., Netzer G., Shanholtz C., et al. (2018). Oxygen exposure resulting in arterial oxygen tensions above the protocol goal was associated with worse clinical outcomes in acute respiratory distress syndrome. Crit. Care Med. 46517–524. 10.1097/CCM.0000000000002886[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Agostoni E., Mead J. (1964). “Statics of the respiratory system,” in Handbook of Physiology Respiration, eds Fenn W. O., Rahn H. (Washington DC: American Physiological Society; ), 387–409. [Google Scholar]
• Amato M. B., Meade M. O., Slutsky A. S., Brochard L., Costa E. L., Schoenfeld D. A., et al. (2015). Driving pressure and survival in the acute respiratory distress syndrome. N. Engl. J. Med. 372747–755. 10.1056/NEJMsa1410639 [PubMed] [CrossRef] [Google Scholar]
• Bachofen H., Hildebrandt J., Bachofen M. (1970). Pressure-volume curves of air- and liquid-filled excised lungs-surface tension in situ. J. Appl. Physiol. 29422–431. 10.1152/jappl.1970.29.4.422 [PubMed] [CrossRef] [Google Scholar]
• Bachofen H., Schürch S., Michel R. P., Weibel E. R. (1993). Experimental hydrostatic pulmonary edema in rabbit lungs. Barrier lesions. Am. Rev. Respir. Dis. 147989–996. 10.1164/ajrccm/147.4.989 [PubMed] [CrossRef] [Google Scholar]
• Bachofen H., Schürch S., Urbinelli M., Weibel E. R. (1987). Relations among alveolar surface tension, surface area, volume, and recoil pressure. J. Appl. Physiol. 621878–1887. 10.1152/jappl.1987.62.5.1878 [PubMed] [CrossRef] [Google Scholar]
• Bachofen M., Weibel E. R. (1974). Basic pattern of tissue repair in human lungs following unspecific injury. Chest 6514S–19S. [PubMed] [Google Scholar]
• Bachofen M., Weibel E. R. (1977). Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am. Rev. Respir. Dis. 116589–615. 10.1164/arrd.1977.116.4.589 [PubMed] [CrossRef] [Google Scholar]
• Bartesaghi M., Beretta E., Pollastri L., Scotti V., Mandolesi G., Lanfranconi F., et al. (2014). Inter-individual differences in control of alveolar capillary blood volume in exercise and hypoxia. Respir. Physiol. Neurobiol. 19096–104. 10.1016/j.resp.2013.08.021 [PubMed] [CrossRef] [Google Scholar]
• Bates J., Gaver D. P., Habashi N. M., Nieman G. F. (2020). Atelectrauma Versus volutrauma: a tale of two time-constants. Crit. Care Explor. 2:e0299. 10.1097/CCE.0000000000000299[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Bates J., Smith B. J. (2018). Ventilator-induced lung injury and lung mechanics. Ann Transl Med. 6 378. 10.21037/atm.2018.06.29[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Beck K. C., Lai-Fook S. J. (1983). Alveolar liquid pressure in excised edematous dog lung with increased static recoil. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 551277–1283. 10.1152/jappl.1983.55.4.1277 [PubMed] [CrossRef] [Google Scholar]
• Bell T. J., Brand O. J., Morgan D. J., Salek-Ardakani S., Jagger C., Fujimori T., et al. (2019). Defective lung function following influenza virus is due to prolonged, reversible hyaluronan synthesis. Matrix Biol. 8014–28. 10.1016/j.matbio.2018.06.006[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Beretta E., Lanfranconi F., Grasso G. S., Bartesaghi M., Alemayehu H. K., Pratali L., et al. (2017a). Air blood barrier phenotype correlates with alveolo-capillary O2 equilibration in hypobaric hypoxia. Respir. Physiol. Neurobiol. 24653–58. 10.1016/j.resp.2017.08.006 [PubMed] [CrossRef] [Google Scholar]
• Beretta E., Lanfranconi F., Grasso G. S., Bartesaghi M., Alemayehu H. K., Miserocchi G. (2017b). Reappraisal of DLCO adjustment to interpret the adaptive response of the air-blood barrier to hypoxia. Respir. Physiol. Neurobiol. 23859–65. 10.1016/j.resp.2016.08.009 [PubMed] [CrossRef] [Google Scholar]
• Berthiaume Y., Matthay M. A. (2007). Alveolar edema fluid clearance and acute lung injury. Respir. Physiol. Neurobiol. 159350–359. 10.1016/j.resp.2007.05.010[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Bo G., Hauge A., Nicolaysen G. (1977). Alveolar pressure and lung volume as determinants of net transvascular fluid filtration. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 42476–482. 10.1152/jappl.1977.42.4.476 [PubMed] [CrossRef] [Google Scholar]
• Botto L., Beretta E., Daffara R., Miserocchi G., Palestini P. (2006). Biochemical and morphological changes in endothelial cells in response to hypoxic interstitial edema. Respir. Res. 7:7. 10.1186/1465-9921-7-7[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Brochard L., Slutsky A., Pesenti A. (2017). Mechanical ventilation to minimize progression of lung injury in acute respiratory failure. Am. J. Respir. Crit. Care Med. 195438–442. 10.1164/rccm.201605-1081CP [PubMed] [CrossRef] [Google Scholar]
• Carteaux G., Millán-Guilarte T., De Prost N., et al. (2016). Failure of noninvasive ventilation for de novo acute hypoxemic respiratory failure: role of tidal volume. Crit. Care Med. 44282–290. 10.1097/CCM.0000000000001379 [PubMed] [CrossRef] [Google Scholar]
• Caser E. B., Zandonade E., Pereira E., Gama A. M., Barbas C. S. (2014). Impact of distinct definitions of acute lung injury on its incidence and outcomes in Brazilian ICUs: prospective evaluation of 7,133 patients*. Crit. Care Med. 42574–582. 10.1097/01.ccm.0000435676.68435.56 [PubMed] [CrossRef] [Google Scholar]
• Cereda M., Xin Y., Hamedani H., Bellani G., Kadlecek S., Clapp J., et al. (2017). Tidal changes on CT and progression of ARDS. Thorax 72981–989. 10.1136/thoraxjnl-2016-209833[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Cereda M., Xin Y., Meeder N., Zeng J., Jiang Y., Hamedani H., et al. (2016). Visualizing the propagation of acute lung injury. Anesthesiology 124121–131. 10.1097/ALN.0000000000000916[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Chow C. W., Herrera Abreu M. T., Suzuki T., Downey G. P. (2003). Oxidative stress and acute lung injury. Am. J. Respir. Cell Mol. Biol. 29427–431. [PubMed] [Google Scholar]
• Clausen T. M., Sandoval D. R., Spliid C. B., Pihl J., Perrett H. R., Painter C. D., et al. (2020). SARS-CoV-2 infection depends on cellular Heparan Sulfate and ACE2. Cell 1831043–1057.e15. 10.1016/j.cell.2020.09.033[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Conforti E., Fenoglio C., Bernocchi G., Bruschi O., Miserocchi G. A. (2002). Morpho-functional analysis of lung tissue in mild interstitial edema. Am. J. Physiol. Lung Cell. Mol. Physiol. 282L766–L774. 10.1152/ajplung.00313.2001 [PubMed] [CrossRef] [Google Scholar]
• Corda M., Voneuler C., Lennerstrand G. (1965). Proprioceptive innervation of the diaphragm. J. Physiol. 178161–177. 10.1113/jphysiol.1965.sp007621[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Cressoni M., Cadringher P., Chiurazzi C., Amini M., Gallazzi E., Marino A., et al. (2014). Lung inhomogeneity in patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 189149–158. 10.1164/rccm.201308-1567OC [PubMed] [CrossRef] [Google Scholar]
• Cressoni M., Gallazzi E., Chiurazzi C., Marino A., Brioni M., Menga F., et al. (2013). Limits of normality of quantitative thoracic CT analysis. Crit. Care 17:R93. 10.1186/cc12738[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Cruces P., Retamal J., Hurtado D. E., Erranz B., Iturrieta P., González C., et al. (2020). A physiological approach to understand the role of respiratory effort in the progression of lung injury in SARS-CoV-2 infection. Crit. Care 24:494. 10.1186/s13054-020-03197-7[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Curry F. R. (2005). Microvascular solute and water transport. Microcirculation 1217–31. 10.1080/10739680590894993 [PubMed] [CrossRef] [Google Scholar]
• Daffara R., Botto L., Beretta E., Conforti E., Faini A., Palestini P., et al. (2004). Endothelial cells as early sensors of pulmonary interstitial edema. J. Appl. Physiol. 971575–1583. 10.1152/japplphysiol.00236.200 [PubMed] [CrossRef] [Google Scholar]
• Dal Magro R., Ornaghi F., Cambianica I., Beretta S., Re F., Musicanti C., et al. (2017). ApoE-modified solid lipid nanoparticles: a feasible strategy to cross the blood-brain barrier. J. Control. Release 10103–110. 10.1016/j.jconrel.2017.01.039 [PubMed] [CrossRef] [Google Scholar]
• Dellacà R. L., Zannin E., Sancini G., Rivolta I., Leone B. E., Pedotti A., et al. (2008). Changes in the mechanical properties of the respiratory system during the development of interstitial lung edema. Respir. Res. 9:51. 10.1186/1465-9921-9-51[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Effros R. M., Parker J. C. (2009). Pulmonary vascular heterogeneity and the Starling hypothesis. Microvasc. Res. 7871–77. 10.1016/j.mvr.2009.03.004 [PubMed] [CrossRef] [Google Scholar]
• Egan E. A. (1980). Response of alveolar epithelial solute permeability to changes in lung inflation. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 491032–1036. 10.1152/jappl.1980.49.6.1032 [PubMed] [CrossRef] [Google Scholar]
• Egan E. A. (1982). Lung inflation, lung solute permeability, and alveolar edema. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 53, 121–125. 10.1152/jappl.1982.53.1.121 [PubMed] [CrossRef] [Google Scholar]
• Egan E. A., Nelson R. M., Gessner I. H. (1977). Solute permeability of the alveolar epithelium in acute hemodynamic pulmonary edema in dogs. Am. J. Physiol. 233H80–H86. 10.1152/ajpheart.1977.233.1.H80 [PubMed] [CrossRef] [Google Scholar]
• Egan E. A., Nelson R. M., Olver R. E. (1976). Lung inflation and alveolar permeability to non-electrolytes in the adult sheep in vivo. J. Physiol. 260409–424. 10.1113/jphysiol.1976.sp011522[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Evans M. J., Cabral L. J., Stephens R. J., Freeman G. (1975). Transformation of alveolar type 2 cells to type 1 cells following exposure to NO2. Exp. Mol. Pathol. 22142–150. 10.1016/0014-4800(75)90059-3 [PubMed] [CrossRef] [Google Scholar]
• Fan E., Brodie D., Slutsky A. S. (2018). Acute respiratory distress syndrome: advances in diagnosis and treatment. JAMA 319698–710. 10.1001/jama.2017.21907 [PubMed] [CrossRef] [Google Scholar]
• Farhangrazi Z. S., Sancini G., Hunter A. C., Moghimi S. M. (2020). Airborne Particulate Matter and SARS-CoV-2 partnership: virus hitchhiking, stabilization and immune cell targeting - a hypothesis. Front. Immunol. 11:579352. 10.3389/fimmu.2020.579352[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Fisher A. B., Dodia C., Chatterjee S. (2021). A peptide inhibitor of peroxiredoxin 6 phospholipase A2 activity significantly protects against lung injury in a mouse model of ventilator induced lung injury (VILI). Antioxidants 10:925. 10.3390/antiox10060925[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Forel J., Roch A., Marin V., Michelet P., Demory D., Blache J., et al. (2006). Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit. Care Med. 34:10. [PubMed] [Google Scholar]
• Freeman B. A., Crapo J. D. (1981). Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J. Biol. Chem. 25610986–10992. [PubMed] [Google Scholar]
• Gattinoni L., Pesenti A. (2005). The concept of “baby lung”. Intensive Care Med. 31776–784. 10.1007/s00134-005-2627-z [PubMed] [CrossRef] [Google Scholar]
• Gaver D. P., III, Nieman G. F., Gatto L. A., Cereda M., Habashi N. M., Bates J. (2020). The POOR Get POORer: a hypothesis for the pathogenesis of ventilator-induced lung injury. Am. J. Respir. Crit. Care Med. 2021081–1087. 10.1164/rccm.202002-0453CP[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Glucksberg M. R., Bhattacharya J. (1991). Effect of alveolar and pleural pressures on interstitial pressures in isolated dog lungs. J. Appl. Physiol. 70914–918. 10.1152/jappl.1991.70.2.914 [PubMed] [CrossRef] [Google Scholar]
• Gorin A. B., Stewart P. A. (1979). Differential permeability of endothelial and epithelial barriers to albumin flux. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 471315–1324. 10.1152/jappl.1979.47.6.1315 [PubMed] [CrossRef] [Google Scholar]
• Habashi N. M. (2005). Other approaches to open-lung ventilation: airway pressure release ventilation. Crit. Care Med. 33S228–S240. 10.1097/01.ccm.0000155920.11893.37 [PubMed] [CrossRef] [Google Scholar]
• Hainis K. D., Sznajder J. I., Schraufnagel D. E. (1994). Lung lymphatics cast from the airspace. Am. J. Physiol. 267(2 Pt 1), L199–L205. 10.1152/ajplung.1994.267.2.L199 [PubMed] [CrossRef] [Google Scholar]
• Hakim T. S., Gilbert E., Camporesi E. (1993). Positive end-expiratory pressure increases capillary pressure relative to wedge pressure in the closed and open chest. J. Crit. Care 880–86. 10.1016/0883-9441(93)90011-9 [PubMed] [CrossRef] [Google Scholar]
• Hamlington K. L., Bates J., Roy G. S., Julianelle A. J., Charlebois C., Suki B., et al. (2018). Alveolar leak develops by a rich-get-richer process in ventilator-induced lung injury. PLoS One 13:e0193934. 10.1371/journal.pone.0193934[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Hassanzadeh K., Perez Pena H., Dragotto J., Buccarello L., Iorio F., Pieraccini S., et al. (2020). Considerations around the SARS-CoV-2 spike protein with particular attention to COVID-19 brain infection and neurological symptoms. ACS Chem. Neurosci. 112361–2369. 10.1021/acschemneuro.0c00373 [PubMed] [CrossRef] [Google Scholar]
• Hedenstierna G., Lattuada M. (2008). Lymphatics and lymph in acute lung injury. Curr. Opin. Crit. Care 1431–36. 10.1097/MCC.0b013e3282f2f4b5 [PubMed] [CrossRef] [Google Scholar]
• Hellman U., Karlsson M. G., Engström-Laurent A., Cajander S., Dorofte L., Ahlm C., et al. (2020). Presence of hyaluronan in lung alveoli in severe Covid-19: An opening for new treatment options? J. Biol. Chem. 29515418–15422. 10.1074/jbc.AC120.015967[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Higuita-Castro N., Nelson M. T., Shukla V., Agudelo-Garcia P. A., Zhang W., Duarte-Sanmiguel S. M., et al. (2017). Using a novel microfabricated model of the alveolar-capillary barrier to investigate the effect of matrix structure on Atelectrauma. Sci. Rep. 7:11623. [PMC free article] [PubMed] [Google Scholar]
• Hou H., Wang T., Zhang B., Luo Y., Mao L., Wang F., et al. (2020). Detection of IgM and IgG antibodies in patients with coronavirus disease 2019. Clin. Transl. Immunol. 9:e01136. 10.1002/cti2.1136[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Huh D., Leslie D. C., Matthews B. D., Fraser J. P., Jurek S., Hamilton G. A., et al. (2012). A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice. Sci. Transl. Med. 4:159ra147. 10.1126/scitranslmed.3004249[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Kallet R. H., Matthay M. A. (2013). Hyperoxic acute lung injury. Respir. Care 58123–141. 10.4187/respcare.01963[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Kapanci Y., Weibel E. R., Kaplan H. P., Robinson F. R. (1969). Pathogenesis and reversibility of the pulmonary lesions of oxygen toxicity in monkeys. II. Ultrastructural and morphometric studies. Lab. Invest. 20101–118. [PubMed] [Google Scholar]
• Kaplan H. P., Robinson F. R., Kapanci Y., Weibel E. R. (1969). Pathogenesis and reversibility of the pulmonary lesions of oxygen toxicity in monkeys. I. Clinical and light microscopic studies. Lab. Invest. 2094–100. [PubMed] [Google Scholar]
• Kistler G. S., Caldwell P. R., Weibel E. R. (1967). Development of fine structural damage to alveolar and capillary lining cells in oxygen-poisoned rat lungs. J. Cell Biol. 32605–628. 10.1083/jcb.32.3.605[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Knudsen L., Ochs M. (2018). The micromechanics of lung alveoli: structure and function of surfactant and tissue components. Histochem. Cell Biol. 150661–676. 10.1007/s00418-018-1747-9[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Kolliputi N., Shaik R. S., Waxman A. B. (2010). The inflammasome mediates hyperoxia-induced alveolar cell permeability. J. Immunol. 1845819–5826. 10.4049/jimmunol.0902766[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Kollisch-Singule M., Emr B., Jain S. V., Andrews P., Satalin J., Liu J., et al. (2015). The effects of airway pressure release ventilation on respiratory mechanics in extrapulmonary lung injury. Intensive Care Med. Exp. 3:35. 10.1186/s40635-015-0071-0[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Kollisch-Singule M., Emr B., Smith B., Roy S., Jain S., Satalin J., et al. (2014a). Mechanical breath profile of airway pressure release ventilation: the effect on alveolar recruitment and microstrain in acute lung injury. JAMA Surg. 1491138–1145. 10.1001/jamasurg.2014.1829 [PubMed] [CrossRef] [Google Scholar]
• Kollisch-Singule M., Emr B., Smith B., Ruiz C., Roy S., Meng Q., et al. (2014b). Airway pressure release ventilation reduces conducting airway micro-strain in lung injury. J. Am. Coll. Surg. 219968–976. 10.1016/j.jamcollsurg.2014.09.011[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Kulkarni A. C., Kuppusamy P., Parinandi N. (2007). Oxygen, the lead actor in the pathophysiologic drama: enactment of the trinity of normoxia, hypoxia, and hyperoxia in disease and therapy. Antioxid. Redox Signal. 91717–1730. 10.1089/ars.2007.1724 [PubMed] [CrossRef] [Google Scholar]
• Lam R., Schilling D., Scottoline B., Platteau A., Niederhausen M., Lund K. C., et al. (2020). The effect of extended continuous positive airway pressure on changes in lung volumes in stable premature infants: a randomized controlled trial. J. Pediatr. 21766–72.e1. 10.1016/j.jpeds.2019.07.074[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Levick J. R., Michel C. C. (2010). Microvascular fluid exchange and the revised Starling principle. Cardiovasc. Res. 87198–210. 10.1093/cvr/cvq062 [PubMed] [CrossRef] [Google Scholar]
• Li Y., Liang J., Yang T., Monterrosa Mena J., Huan C., Xie T., et al. (2016). Hyaluronan synthase 2 regulates fibroblast senescence in pulmonary fibrosis. Matrix Biol. 5535–48. 10.1016/j.matbio.2016.03.004[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Li Y., Rahmanian M., Widström C., Lepperdinger G., Frost G. I., Heldin P. (2000). Irradiation-induced expression of hyaluronan (HA) synthase 2 and hyaluronidase 2 genes in rat lung tissue accompanies active turnover of HA and induction of types I and III collagen gene expression. Am. J. Respir. Cell Mol. Biol. 23411–418. 10.1165/ajrcmb.23.3.4102 [PubMed] [CrossRef] [Google Scholar]
• Liang S., Wang Y., Liu Y. (2019). Dexmedetomidine alleviates lung ischemia-reperfusion injury in rats by activating PI3K/Akt pathway. Eur. Rev. Med. Pharmacol. Sci. 23370–377. 10.26355/eurrev_201901_16785 [PubMed] [CrossRef] [Google Scholar]
• Lin C. Y., Zhang H., Cheng K. C., Slutsky A. S. (2003). Mechanical ventilation may increase susceptibility to the development of bacteremia. Crit. Care Med. 311429–1434. 10.1097/01.CCM.0000063449.58029.81 [PubMed] [CrossRef] [Google Scholar]
• Long Q. X., Liu B. Z., Deng H. J., Wu G. C., Deng K., Chen Y. K., et al. (2020). Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat. Med. 26845–848. 10.1038/s41591-020-0897-1 [PubMed] [CrossRef] [Google Scholar]
• Makiyama A. M., Gibson L. J., Harris R. S., Venegas J. G. (2014). Stress concentration around an atelectatic region: a finite element model. Respir. Physiol. Neurobiol. 201101–110. 10.1016/j.resp.2014.06.017 [PubMed] [CrossRef] [Google Scholar]
• Matalon S., Egan E. A. (1981). Effects of 100% O2 breathing on permeability of alveolar epithelium to solute. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 50859–863. 10.1152/jappl.1981.50.4.859 [PubMed] [CrossRef] [Google Scholar]
• Matalon S., Egan E. A. (1984). Interstitial fluid volumes and albumin spaces in pulmonary oxygen toxicity. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 571767–1772. 10.1152/jappl.1984.57.6.1767 [PubMed] [CrossRef] [Google Scholar]
• Matsuzawa Y., Nakazawa K., Yamamura A., Akashi T., Kitagaki K., Eishi Y., et al. (2010). Airway pressure release ventilation reduces the increase in bronchoalveolar lavage fluid high-mobility group box-1 levels and lung water in experimental acute respiratory distress syndrome induced by lung lavage. Eur. J. Anaesthesiol. 27726–733. 10.1097/EJA.0b013e328333c2b0 [PubMed] [CrossRef] [Google Scholar]
• Matthay M. A., Wiener-Kronish J. P. (1990). Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am. Rev. Respir. Dis. 142(6 Pt 1), 1250–1257. 10.1164/ajrccm/142.6_Pt_1.1250 [PubMed] [CrossRef] [Google Scholar]
• Matthay M. A., Landolt C. C., Staub N. C. (1982). Differential liquid and protein clearance from the alveoli of anesthetized sheep. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 5396–104. 10.1152/jappl.1982.53.1.96 [PubMed] [CrossRef] [Google Scholar]
• Mazzuca E., Aliverti A., Miserocchi G. (2019). Understanding vasomotion of lung microcirculation by in vivo imaging. J. Imaging 5:22. 10.3390/jimaging5020022[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Mazzuca E., Aliverti A., Miserocchi G. (2016). Computational micro-scale model of control of extravascular water and capillary perfusion in the air blood barrier. J. Theor. Biol. 40042–51. 10.1016/j.jtbi.2016.03.036 [PubMed] [CrossRef] [Google Scholar]
• Mead J., Takishima T., Leith D. (1970). Stress distribution in lungs: a model of pulmonary elasticity. J. Appl. Physiol. 28596–608. 10.1152/jappl.1970.28.5.596 [PubMed] [CrossRef] [Google Scholar]
• Miserocchi G. (2007). “Lung interstitial pressure and structure in acute hypoxia,” in Hypoxia and the Circulation, eds Roach R. C., Wagner P. D., Hackett P. H. (New York, NY: Springer; ). [Google Scholar]
• Miserocchi G., Poskurica B. H., del Fabbro M., Crisafulli B. (1995). Pulmonary interstitial pressure in premature rabbits. Respir. Physiol. 102239–249. 10.1016/0034-5687(95)00070-4 [PubMed] [CrossRef] [Google Scholar]
• Miserocchi G., Rivolta I. (2012). Mechanistic considerations on the development of lung edema: vascular, perivascular and molecular aspects from early stage to tissue and vascular remodeling. Curr. Respir. Med. Rev. 882–89. [Google Scholar]
• Miserocchi G. (2009). Mechanisms controlling the volume of pleural fluid and extravascular lung water. Eur. Respir. Rev. 18244–252. 10.1183/09059180.00002709 [PubMed] [CrossRef] [Google Scholar]
• Miserocchi G., Messinesi G., Tana F., Passoni E., Adamo S., Romano R., et al. (2008). Mechanisms behind inter-individual differences in lung diffusing capacity. Eur. J. Appl. Physiol. 102561–568. 10.1007/s00421-007-0625-2 [PubMed] [CrossRef] [Google Scholar]
• Miserocchi G., Negrini D., Gonano C. (1990). Direct measurement of interstitial pulmonary pressure in in situ lung with intact pleural space. J. Appl. Physiol. 692168–2174. 10.1152/jappl.1990.69.6.2168 [PubMed] [CrossRef] [Google Scholar]
• Miserocchi G., Negrini D., Del Fabbro M., Venturoli D. (1993). Pulmonary interstitial pressure in intact in situ lung: transition to interstitial edema. J. Appl. Physiol. 741171–1177. 10.1152/jappl.1993.74.3.1171 [PubMed] [CrossRef] [Google Scholar]
• Miserocchi G., Negrini D., Mukenge S., Turconi P., Del Fabbro M. (1989). Liquid drainage through the peritoneal diaphragmatic surface. J. Appl. Physiol. 661579–1585. 10.1152/jappl.1989.66.4.1579 [PubMed] [CrossRef] [Google Scholar]
• Miserocchi G., Passi A., Albertini R., Negrini D., De Luca G. (1999). Interstitial pressure and proteoglycan degradation in hydraulic- and elastase-induced lung edema. Chest 116(1 Suppl.):31S. 10.1378/chest.116.suppl_1.31s [PubMed] [CrossRef] [Google Scholar]
• Miserocchi G., Passi A., Negrini D., Del Fabbro M., De Luca G. (2001). Pulmonary interstitial pressure and tissue matrix structure in acute hypoxia. Am. J. Physiol. Lung Cell. Mol. Physiol. 280L881–L887. 10.1152/ajplung.2001.280.5.L881 [PubMed] [CrossRef] [Google Scholar]
• Miserocchi G., Poskurica B. H., Del Fabbro M. (1994). Pulmonary interstitial pressure in anesthetized paralyzed newborn rabbits. J. Appl. Physiol. 772260–2268. 10.1152/jappl.1994.77.5.2260 [PubMed] [CrossRef] [Google Scholar]
• Mitzner W., Sylvester J. T. (1986). Lymph flow and lung weight in isolated sheep lungs. J. Appl. Physiol. 611830–1835. 10.1152/jappl.1986.61.5.1830 [PubMed] [CrossRef] [Google Scholar]
• Nash G., Blennerhassett J. B., Pontoppidan H. (1967). Pulmonary lesions associated with oxygen therapy and artifical ventilation. N. Engl. J. Med. 276368–374. 10.1056/NEJM196702162760702 [PubMed] [CrossRef] [Google Scholar]
• Negrini D., Passi A., Bertin K., Bosi F., Wiig H. (2001b). Isolation of pulmonary interstitial fluid in rabbits by a modified wick technique. Am. J. Physiol. Lung Cell. Mol. Physiol. 280L1057–L1065. 10.1152/ajplung.2001.280.5.L1057 [PubMed] [CrossRef] [Google Scholar]
• Negrini D., Candiani A., Boschetti F., Crisafulli B., Del Fabbro M., Bettinelli D., et al. (2001a). Pulmonary microvascular and perivascular interstitial geometry during development of mild hydraulic edema. Am. J. Physiol. Lung Cell. Mol. Physiol. 281L1464–L1471. 10.1152/ajplung.2001.281.6.L1464 [PubMed] [CrossRef] [Google Scholar]
• Negrini D., Passi A., de Luca G., Miserocchi G. (1996). Pulmonary interstitial pressure and proteoglycans during development of pulmonary edema. Am. J. Physiol. 270(6 Pt 2), H2000–H2007. 10.1152/ajpheart.1996.270.6.H2000 [PubMed] [CrossRef] [Google Scholar]
• Nieman G. F., Andrews P., Satalin J., Wilcox K., Kollisch-Singule M., Madden M., et al. (2018). Acute lung injury: how to stabilize a broken lung. Crit. Care 22:136. 10.1186/s13054-018-2051-8[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Nieman G. F., Gatto L. A., Andrews P., Satalin J., Camporota L., Daxon B., et al. (2020b). Prevention and treatment of acute lung injury with time-controlled adaptive ventilation: physiologically informed modification of airway pressure release ventilation. Ann. Intensive Care 10:3. 10.1186/s13613-019-0619-3[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Nieman G. F., Al-Khalisy H., Kollisch-Singule M., Satalin J., Blair S., Trikha G., et al. (2020a). A physiologically informed strategy to effectively open, stabilize, and protect the acutely injured lung. Front. Physiol. 11:227. 10.3389/fphys.2020.00227[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Palestini P., Botto L., Rivolta I., Miserocchi G. (2011). Remodelling of membrane rafts expression in lung cells as an early sign of mechanotransduction-signalling in pulmonary edema. J. Lipids 2011:695369. 10.1155/2011/695369[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Palestini P., Calvi C., Conforti E., Botto L., Fenoglio C., Miserocchi G. (2002). Composition, biophysical properties, and morphometry of plasma membranes in pulmonary interstitial edema. Am. J. Physiol. Lung Cell Mol. Physiol. 282L1382–L1390. 10.1152/ajplung.00447.2001 [PubMed] [CrossRef] [Google Scholar]
• Papazian L., Forel J. M., Gacouin A., Penot-Ragon C., Perrin G., Loundou A., et al. (2010). Neuromuscular blockers in early acute respiratory distress syndrome. N. Engl. J. Med. 3631107–1116. [PubMed] [Google Scholar]
• Parker J. C. (2007). Hydraulic conductance of lung endothelial phenotypes and Starling safety factors against edema. Am. J. Physiol. Lung Cell. Mol. Physiol. 292L378–L380. 10.1152/ajplung.00196.2006 [PubMed] [CrossRef] [Google Scholar]
• Parker J. C., Guyton A. C., Taylor A. E. (1978). Pulmonary interstitial and capillary pressures estimated from intra-alveolar fluid pressures. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 44267–276. 10.1152/jappl.1978.44.2.267 [PubMed] [CrossRef] [Google Scholar]
• Parker J. C., Ivey C. L., Tucker J. A. (1998). Gadolinium prevents high airway pressure-induced permeability increases in isolated rat lungs. J. Appl. Physiol. 841113–1118. 10.1152/jappl.1998.84.4.1113 [PubMed] [CrossRef] [Google Scholar]
• Parker J. C., Stevens T., Randall J., Weber D. S., King J. A. (2006). Hydraulic conductance of pulmonary microvascular and macrovascular endothelial cell monolayers. Am. J. Physiol. Lung Cell. Mol. Physiol. 291L30–L37. 10.1152/ajplung.00317.2005 [PubMed] [CrossRef] [Google Scholar]
• Parker J. C., Townsley M. I. (2004). Evaluation of lung injury in rats and mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 286L231–L246. 10.1152/ajplung.00049.2003 [PubMed] [CrossRef] [Google Scholar]
• Parker J. C., Townsley M. I., Rippe B., Taylor A. E., Thigpen J. (1984). Increased microvascular permeability in dog lungs due to high peak airway pressures. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 571809–1816. 10.1152/jappl.1984.57.6.1809 [PubMed] [CrossRef] [Google Scholar]
• Passi A., Negrini D., Albertini R., Miserocchi G., De Luca G. (1999). The sensitivity of versican from rabbit lung to gelatinase A (MMP-2) and B (MMP-9) and its involvement in the development of hydraulic lung edema. FEBS Lett. 45693–96. 10.1016/s0014-5793(99)00929-1 [PubMed] [CrossRef] [Google Scholar]
• Patel V., Dial K., Wu J., Gauthier A. G., Wu W., Lin M., et al. (2020). Dietary antioxidants significantly attenuate Hyperoxia-induced acute inflammatory lung injury by enhancing macrophage function via reducing the accumulation of airway HMGB1. Int. J. Mol. Sci. 21:977. 10.3390/ijms21030977[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Pearse D. B., Wagner E. M., Sylvester J. T. (1993). Edema clearance in isolated sheep lungs. J. Appl. Physiol. 74126–132. 10.1152/jappl.1993.74.1.126 [PubMed] [CrossRef] [Google Scholar]
• Pengelly L. D., Alderson A. M., Milic-Emili J. (1971). Mechanics of the diaphragm. J. Appl. Physiol. 30797–805. 10.1152/jappl.1971.30.6.797 [PubMed] [CrossRef] [Google Scholar]
• Perlman C. E., Lederer D. J., Bhattacharya J. (2011). Micromechanics of alveolar edema. Am. J. Respir. Cell. Mol. Biol. 4434–39. 10.1165/rcmb.2009-0005OC[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Protti A., Andreis D. T., Monti M., Santini A., Sparacino C. C., Langer T., et al. (2013). Lung stress and strain during mechanical ventilation: Any difference between statics and dynamics? Crit. Care Med. 411046–1055. 10.1097/CCM.0b013e31827417a6 [PubMed] [CrossRef] [Google Scholar]
• Rausch S. M., Haberthür D., Stampanoni M., Schittny J. C., Wall W. A. (2011). Local strain distribution in real three-dimensional alveolar geometries. Ann. Biomed. Eng. 392835–2843. 10.1007/s10439-011-0328-z [PubMed] [CrossRef] [Google Scholar]
• Reitsma S., Slaaf D. W., Vink H., van Zandvoort M. A., oude Egbrink M. G. (2007). The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch. 454345–359. 10.1007/s00424-007-0212-8[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Retamal J., Hurtado D., Villarroel N., Bruhn A., Bugedo G., Amato M., et al. (2018). Does regional lung strain correlate with regional inflammation in acute respiratory distress syndrome during nonprotective ventilation? An Experimental Porcine Study. Crit. Care Med. 46e591–e599. 10.1097/CCM.0000000000003072 [PubMed] [CrossRef] [Google Scholar]
• Rivolta I., Lucchini V., Rocchetti M., Kolar F., Palazzo F., Zaza A., et al. (2011). Interstitial pressure and lung oedema in chronic hypoxia. Eur. Respir. J. 37943–949. 10.1183/09031936.00066710 [PubMed] [CrossRef] [Google Scholar]
• Robinson S. K., Ramsden J. J., Warner J., Lackie P. M., Roose T. (2019). Correlative 3D Imaging and Microfluidic Modelling of Human Pulmonary Lymphatics using Immunohistochemistry and High-resolution μCT. Sci. Rep. 9:6415. 10.1038/s41598-019-42794-7[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Roselli R. J., Parker R. E., Harris T. R. (1984). A model of unsteady-state transvascular fluid and protein transport in the lung. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 561389–1402. 10.1152/jappl.1984.56.5.1389 [PubMed] [CrossRef] [Google Scholar]
• Roy S. K., Emr B., Sadowitz B., Gatto L. A., Ghosh A., Satalin J. M., et al. (2013a). Preemptive application of airway pressure release ventilation prevents development of acute respiratory distress syndrome in a rat traumatic hemorrhagic shock model. Shock 40210–216. 10.1097/SHK.0b013e31829efb06[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Roy S., Habashi N., Sadowitz B., Andrews P., Ge L., Wang G., et al. (2013b). Early airway pressure release ventilation prevents ARDS-a novel preventive approach to lung injury. Shock 3928–38. 10.1097/SHK.0b013e31827b47bb[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Roy S., Sadowitz B., Andrews P., Gatto L. A., Marx W., Ge L., et al. (2012). Early stabilizing alveolar ventilation prevents acute respiratory distress syndrome: a novel timing-based ventilatory intervention to avert lung injury. J. Trauma Acute Care Surg. 73391–400. 10.1097/TA.0b013e31825c7a82[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Rutili G., Kvietys P., Martin D., Parker J. C., Taylor A. E. (1982). Increased pulmonary microvasuclar permeability induced by alpha-naphthylthiourea. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 521316–1323. 10.1152/jappl.1982.52.5.1316 [PubMed] [CrossRef] [Google Scholar]
• Scherrer U., Vollenweider L., Delabays A., Savcic M., Eichenberger U., Kleger G. R., et al. (1996). Inhaled nitric oxide for high-altitude pulmonary edema. N. Engl. J. Med. 334624–629. 10.1056/NEJM199603073341003 [PubMed] [CrossRef] [Google Scholar]
• Schraufnagel D. E. (1992). Forms of lung lymphatics: a scanning electron microscopic study of casts. Anat. Rec. 233547–554. 10.1002/ar.1092330409 [PubMed] [CrossRef] [Google Scholar]
• Schraufnagel D. E., Agaram N. P., Faruqui A., Jain S., Jain L., Ridge K. M., et al. (2003). Pulmonary lymphatics and edema accumulation after brief lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 284L891–L897. 10.1152/ajplung.00333.2002 [PubMed] [CrossRef] [Google Scholar]
• Schraufnagel D. E., Basterra J. L., Hainis K., Sznajder J. I. (1994). Lung lymphatics increase after hyperoxic injury. Am. J. Pathol. 1441393–1402. [PMC free article] [PubMed] [Google Scholar]
• Smith B. J., Roy G. S., Cleveland A., Mattson C., Okamura K., Charlebois C. M., et al. (2020). Three alveolar phenotypes govern lung function in murine ventilator-induced lung injury. Front. Physiol. 11:660. 10.3389/fphys.2020.00660[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Tarbell J. M. (2010). Shear stress and the endothelial transport barrier. Cardiovasc. Res. 87320–330. 10.1093/cvr/cvq146[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Tarbell J. M., Demaio L., Zaw M. M. (1999). Effect of pressure on hydraulic conductivity of endothelial monolayers: role of endothelial cleft shear stress. J. Appl. Physiol. 87261–268. 10.1152/jappl.1999.87.1.261 [PubMed] [CrossRef] [Google Scholar]
• Taylor A. E., Parker J. C. (1985). “Pulmonary interstitial spaces and lymphatics” in Handbook of Physiology. The Respiratory System and Nonrespiratory Functions,eds Fishman A., Fisher A. (Bethesda, MD: American Physiological Society; ) 167–230. [Google Scholar]
• Telias I., Brochard L., Goligher E. C. (2018). Is my patient’s respiratory drive (too) high? Intensive Care Med. 441936–1939. 10.1007/s00134-018-5091-2 [PubMed] [CrossRef] [Google Scholar]
• Tingay D. G., Farrell O., Thomson J., Perkins E. J., Pereira-Fantini P. M., Waldmann A. D., et al. (2021). Imaging the respiratory transition at birth: unraveling the complexities of the first breaths of life. Am. J. Respir. Crit. Care Med. 20482–91. 10.1164/rccm.202007-2997OC [PubMed] [CrossRef] [Google Scholar]
• Unruh H. W., Goldberg H. S., Oppenheimer L. (1984). Pulmonary interstitial compartments and tissue resistance to fluid flux. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 571512–1519. 10.1152/jappl.1984.57.5.1512 [PubMed] [CrossRef] [Google Scholar]
• Verghese G. M., Ware L. B., Matthay B. A., Matthay M. A. (1999). Alveolar epithelial fluid transport and the resolution of clinically severe hydrostatic pulmonary edema. J. Appl. Physiol. 871301–1312. 10.1152/jappl.1999.87.4.1301 [PubMed] [CrossRef] [Google Scholar]
• Ware L. B., Matthay M. A. (2001). Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 1631376–1383. 10.1164/ajrccm.163.6.2004035 [PubMed] [CrossRef] [Google Scholar]
• Waxman A. B., Kolliputi N. (2009). IL-6 protects against hyperoxia-induced mitochondrial damage via Bcl-2-induced Bak interactions with mitofusins. Am. J. Respir. Cell Mol. Biol. 41385–396. 10.1165/rcmb.2008-0302OC[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Weber E., Sozio F., Borghini A., Sestini P., Renzoni E. (2018). Pulmonary lymphatic vessel morphology: a review. Ann. Anat. 218110–117. 10.1016/j.aanat.2018.02.011 [PubMed] [CrossRef] [Google Scholar]
• Weibel E. R. (1971). Oxygen effect on lung cells. Arch. Intern. Med. 12854–56. 10.1001/archinte.1971.00310190058005 [PubMed] [CrossRef] [Google Scholar]
• Weibel E. R. (2015). On the tricks alveolar epithelial cells play to make a good lung. Am. J. Respir. Crit. Care Med. 191504–513. 10.1164/rccm.201409-1663OE [PubMed] [CrossRef] [Google Scholar]
• Weibel E. R. (2017). Lung morphometry: the link between structure and function. Cell Tissue Res. 367413–426. 10.1007/s00441-016-2541-4 [PubMed] [CrossRef] [Google Scholar]
• Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial (ART) Investigators, Cavalcanti A. B., Suzumura É. A., Laranjeira L. N., Paisani D. M., Damiani L. P., et al. (2017). Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on mortality in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA 3181335–1345. 10.1001/jama.2017.14171[PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Wu D. X., Weibel E. R., Bachofen H., Schürch S. (1995). Lung lesions in experimental hydrostatic pulmonary edema: an electron microscopic and morphometric study. Exp. Lung Res. 21711–730. 10.3109/01902149509050838 [PubMed] [CrossRef] [Google Scholar]
• Yoshida T., Rinka H., Kaji A., Yoshimoto A., Arimoto H., Miyaichi T., et al. (2009). The impact of spontaneous ventilation on distribution of lung aeration in patients with acute respiratory distress syndrome: airway pressure release ventilation versus pressure support ventilation. Anesth. Analg. 1091892–1900. 10.1213/ANE.0b013e3181bbd918 [PubMed] [CrossRef] [Google Scholar] Yoshikawa S., King J. A., Lausch R. N., Penton A. M., Eyal F. G., Parker J. C. (2004). Acute ventilator-induced vascular permeability and cytokine responses in isolated and in situ mouse lungs.